Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice

Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity

(2017) Guillemette Crépeaux et al.   TOXICOLOGY

Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes

(2017) Mohammed Y.E. Chowdhury et al.   VETERINARY MICROBIOLOGY

Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine

(2017) Jihyun Yang et al.   Scientific Reports

Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations

(2016) Matthew Mold et al.   Scientific Reports

Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity

(2013) C. A. Shaw et al.   IMMUNOLOGIC RESEARCH

Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes

(2013) C.A. Shaw et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection

(2013) Rui-Yuan Cao et al.   PLoS One

Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus

(2012) Ho-Jin Moon et al.   VETERINARY MICROBIOLOGY

Type 1 Interferons and Antiviral CD8 T-Cell Responses

(2012) Raymond M. Welsh et al.   PLoS Pathogens

Aluminum Vaccine Adjuvants: Are they Safe?

(2011) L. Tomljenovic et al.   CURRENT MEDICINAL CHEMISTRY

Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection

(2011) Emily Jane Bek et al.   VACCINE

Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine

(2011) Chun-Wei Chen et al.   VACCINE

Hand foot and mouth disease due to enterovirus 71 in Malaysia

(2011) Kaw Bing Chua et al.   VIROLOGICA SINICA

New Biological Functions and Applications of High-Molecular-Mass Poly-γ-glutamic Acid

(2010) Haryoung Poo et al.   CHEMISTRY & BIODIVERSITY

Modulation of Gene Expression Related to Toll-Like Receptor Signaling in Dendritic Cells by Poly( -Glutamic Acid) Nanoparticles

(2010) T. Hamasaki et al.   Clinical and Vaccine Immunology

Virology, epidemiology, pathogenesis, and control of enterovirus 71

(2010) Tom Solomon et al.   LANCET INFECTIOUS DISEASES

Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy

(2010) Sissela Broos et al.   VACCINE

Bacillus subtilis-specific poly- -glutamic acid regulates development pathways of naive CD4+ T cells through antigen-presenting cell-dependent and -independent mechanisms

(2009) S. Kim et al.   INTERNATIONAL IMMUNOLOGY

Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease

(2009) K. C. Ong et al.   JOURNAL OF VIROLOGY

Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection

(2008) Hsiao-Ling Chen et al.   VACCINE

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

(2008) Yao-Chi Chung et al.   VACCINE